中药塌渍联合护理干预良性前列腺增生患者下尿路症状的临床研究
Clinical Study on the Management of Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia Using Traditional Chinese Medicine Compress Combined with Nursing Intervention
摘要: (1) 目的：探究中药塌渍联合系统护理干预对良性前列腺增生患者下尿路症状的临床效果。(2) 方法：选取70例患者，随机分为实验组与对照组各35例。两组均口服坦索罗辛并接受常规护理。实验组加用12周的中药塌渍治疗。观察指标包括国际前列腺症状评分(IPSS)、夜尿次数、膀胱残余尿量、生活质量指数评分(QoL)及中医证候积分。(3) 结果：实验组IPSS评分从(20.36 ± 3.25)分降至(13.14 ± 2.87)分，降幅大于对照组(P < 0.05)。夜尿次数由(3.82 ± 0.86)次减少至(1.94 ± 0.63)次，下降更明显(P < 0.05)。膀胱残余尿量实验组降至(48.62 ± 10.74) mL，减少幅度于对照组(P < 0.05)。实验组QoL评分及中医证候积分下降也更为显著(P均<0.05)。(4) 结论：中药塌渍联合护理干预可有效改善良性前列腺增生患者的下尿路症状，减少夜尿，提升其生活质量和中医证候表现。
Abstract: (1) Objective: To investigate the clinical efficacy of Traditional Chinese Medicine (TCM) compress combined with systematic nursing intervention in managing lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). (2) Methods: A total of 70 patients were enrolled and randomly assigned to either an experimental group or a control group, with 35 patients in each group. Both groups received oral tamsulosin and routine nursing care. In addition, the experimental group underwent TCM compress therapy for 12 consecutive weeks. The outcome measures included the International Prostate Symptom Score (IPSS), nocturia frequency, post-void residual (PVR) urine volume, Quality of Life index score (QoL), and TCM syndrome score. (3) Results: In the experimental group, the IPSS decreased from 20.36 ± 3.25 to 13.14 ± 2.87, representing a significantly greater reduction compared to the control group (P < 0.05). Nocturia frequency decreased from 3.82 ± 0.86 to 1.94 ± 0.63 times per night, with a more pronounced reduction than in the control group (P < 0.05). The PVR urine volume in the experimental group decreased to 48.62 ± 10.74 mL, with a significantly greater reduction compared to the control group (P < 0.05). Furthermore, the reductions in QoL score and TCM syndrome score were also significantly greater in the experimental group than in the control group (both P < 0.05). (4) Conclusion: TCM compress combined with nursing intervention can effectively alleviate lower urinary tract symptoms in patients with benign prostatic hyperplasia, reduce nocturia frequency, and improve both quality of life and TCM syndrome manifestations.
文章引用：罗中华, 唐梅, 黄开荣, 苏崎. 中药塌渍联合护理干预良性前列腺增生患者下尿路症状的临床研究[J]. 中医学, 2026, 15(6): 54-61. https://doi.org/10.12677/tcm.2026.156312

参考文献

[1] 良性前列腺增生诊疗及健康管理指南[J]. 中华男科学杂志, 2022, 28(4): 356-365.
[2] 于文晓. 良性前列腺增生症中西医结合多学科诊疗指南(2022版) [J]. 中国男科学杂志, 2022, 36(2): 96-102.
[3] 朱自强, 康健. 良性前列腺增生最新研究进展[J]. 临床泌尿外科杂志, 2019, 34(5): 409-412.
[4] 王政昊, 白云金, 张兴明, 等. 不同手术方式治疗大体积良性前列腺增生的有效性和安全性的网状Meta分析[J]. 中国循证医学杂志, 2020, 20(12): 1413-1420.
[5] 汪仁昊, 潘铁军, 谢秋波, 等. 良性前列腺增生微创手术方式进展[J]. 临床泌尿外科杂志, 2024, 39(1): 83-88.
[6] 杨光林, 莫林键, 杨丹凌, 等. 激光手术治疗大体积良性前列腺增生的应用现状[J]. 国际泌尿系统杂志, 2023, 43(3): 542-545.
[7] 郑入文, 蒋静, 宁艳哲, 等. 中医对良性前列腺增生的认识及治疗现状[J]. 世界中医药, 2017, 12(8): 1974-1978.
[8] 韩敏, 何席呈, 吴珊珊, 等. 基于“肾主水”探讨肾阳虚多尿的病机与论治[J]. 中医临床研究, 2025, 17(23): 103-109.
[9] 王晨, 王祖龙, 华众, 等. 基于男子以肾为本理论浅述从肾论治男科疾病[J]. 中华中医药杂志, 2021, 36(12): 7152-7155.
[10] 黄登霞, 张春和, 肖子浩, 等. 男科疾病的中医外治法研究进展[J]. 中国民族民间医药, 2023, 32(3): 44-50.
[11] 李波男, 孙天松, 周兴, 等. 谭新华运用中医外治法治疗男科疾病验案举隅[J]. 中国性科学, 2024, 33(4): 136-140.
[12] 张祥华, 王行环, 王刚, 等. 良性前列腺增生临床诊治指南[J]. 中华外科杂志, 2007, 45(24): 1704-1707.
[13] 徐凌, 冯建伟, 郎金田, 等. 3种不同α受体阻滞剂治疗良性小体积前列腺增生伴下尿路症状患者临床比较[J]. 川北医学院学报, 2023, 38(6): 810-813+817.
[14] 李鹏. α-受体阻滞剂单用或与M-受体阻滞剂联合治疗良性前列腺增生的临床效果分析[J]. 中国实用医药, 2025, 20(11): 16-20.
[15] 侯媛之, 陶方泽, 王陶立, 等. 中医男科诊疗规范化建设现状: 基于指南与共识的系统梳理[J/OL]. 中国实验方剂学杂志: 1-10. https://link.cnki.net/doi/10.13422/j.cnki.syfjx.20260998, 2026-04-07.[CrossRef] 
[16] 叶倩倩, 潘逸迁, 叶小明, 等. 中药穴位贴敷联合经皮电神经刺激防治前列腺增生患者TURP术后膀胱痉挛的疗效观察[J]. 中国中医药科技, 2025, 32(3): 486-488.
[17] 危椠罡, 许碧香, 任新生, 等. 基于“气血交互于脉”探讨穴位敷贴在糖尿病周围神经病变中的应用[J]. 中国卫生标准管理, 2023, 14(13): 158-162.
[18] 陈少婉, 胡颜. 常规护理联合中医特色护理对前列腺增生患者的作用观察[J]. 中国典型病例大全, 2026, 20(1): 873-877.
[19] 王曼莉, 刘香红, 赵国红, 等. 穴位按摩联合养肾贴干预前列腺增生肾阳虚证患者夜尿次数的护理观察[J]. 临床医学研究与实践, 2026, 11(2): 150-153.
[20] 王淼, 边小平, 秦晓光. 近十年中医外治法治疗良性前列腺增生症研究概况[J]. 亚太传统医药, 2020, 16(5): 200-203.